LCI699(928134-65-0)
- Name: LCI699
- Synonyms:(R)-4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile;4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile;3-
quinoline;4-((R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluoro-benzonitrile;4-(quinolin-3-ylmethyl-amino)-benzenesulfonamide;Novartis LCI699; - Molecular Formula:C13H10FN3
- Molecular Weight:227.241
- CAS Registry Number:928134-65-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 851627-80-0/Benzamide, 2-[(2-bromoethyl)[2-[(methylsulfonyl)oxy]ethyl]amino]-3,5-dinitro-N-[2-(phosphonooxy)ethyl]-, monosodium salt (9CI)
- 204067-52-7/FR-194738
- 1264191-73-2/VTP-27999 (Hydrochloride)
- 136236-49-2/S-PAI (hydrochloride)
- 1186222-89-8/4SC-202
- 6501-72-0/4,5-Dihydro-3-phenyl-5-isoxazoleaceticacid
- 854756-74-4/ALB-109564
- 1233749-00-2/(S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol
- 1050506-87-0/Benzenepropanoic acid, 4-[[4-(2-chlorophenyl)-2-thiazolyl]methoxy]-2-methyl-
- 937272-79-2/Pacritinib
- 36745-93-4/2,4-Dichloro-6-methyl-5-pyrimidinecarboxylic acid methyl ester
- 890087-21-5/LUF 6000
- 899805-25-5/CC 930
- 933474-26-1/Meayamycin
- 211516-63-1/Benzo[3,4]-18-norandrosta-3,5-diene-3(2'H)-carboxylic acid, 3',4',5',6'-tetrahydro-4',4',9,14-tetraMethyl-17-oxo-, Methyl ester, (3β,4β,8α,9β,10α,13α,14β)- (9CI)
- 770691-21-9/GADOBUTROL
- 784210-87-3/RGB-286638
- 1315355-93-1/NG-25
- 1312005-62-1/YF-2
- 928134-65-0/LCI699
- 1003566-93-5/AZD 4818
- 1374601-41-8/BRD-9539
- 266359-93-7/R-(-)-2-(4-ISOBUTYLPHENYL)PROPIONYL METHANSULPHONAMIDE, LYSINE SALT
- 1262238-11-8/INCB3344
- 496794-70-8/GLI1-Mediated transcription inhibitor
- 1255580-76-7/UNC0638
- 937263-43-9/Irbinitinib
- 1227911-45-6/GSK 2334470
- 1256578-99-0/6-broMo-7-Methoxy-1,1-diMethyl-3,4-dihydronaphthalen-2(1H)-one,
- 1370261-97-4/PRT062607 (Hydrochloride)